277.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$278.23
Offen:
$280
24-Stunden-Volumen:
672.55K
Relative Volume:
0.85
Marktkapitalisierung:
$22.98B
Einnahmen:
$13.77B
Nettoeinkommen (Verlust:
$856.40M
KGV:
27.22
EPS:
10.1824
Netto-Cashflow:
$1.38B
1W Leistung:
+2.09%
1M Leistung:
+6.45%
6M Leistung:
+6.27%
1J Leistung:
+11.89%
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
277.20 | 23.07B | 13.77B | 856.40M | 1.38B | 10.18 |
|
TMO
Thermo Fisher Scientific Inc
|
542.83 | 203.77B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
216.61 | 152.51B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
644.61 | 51.39B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
129.58 | 36.75B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
187.49 | 30.69B | 15.90B | 1.28B | 2.21B | 7.2842 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Holdings Inc. $LH is Diamond Hill Capital Management Inc.'s 10th Largest Position - MarketBeat
JP Morgan Raises Price Target for Labcorp Hldgs (LH) to $319 | L - GuruFocus
Labcorp (NYSE:LH) Given New $319.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Willis Investment Counsel Sells 4,728 Shares of Labcorp Holdings Inc. $LH - MarketBeat
JPMorgan Adjusts Price Target on Labcorp Holdings to $319 From $317, Maintains Overweight Rating - marketscreener.com
Bessemer Group Inc. Raises Stake in Labcorp Holdings Inc. $LH - MarketBeat
Stock Report: Is Labcorp Holdings Inc attractive for institutional investors2025 Earnings Surprises & Weekly Market Pulse Updates - baoquankhu1.vn
Labcorp Extends Receivables Facility As Shares Trade Below Estimated Value - Sahm
Allianz Asset Management GmbH Has $61.88 Million Stake in Labcorp Holdings Inc. $LH - MarketBeat
Assessing Labcorp Holdings (LH) Valuation After Guidance Cut And Restructuring Response - Yahoo Finance
Here's Why Labcorp (LH) is a Strong Value Stock - sharewise.com
Rep. April McClain Delaney Buys Labcorp Holdings Inc. (NYSE:LH) Shares - MarketBeat
Investor Concerns Impacted Labcorp (LH) in Q4 - Finviz
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
National Pension Service Raises Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. $LH Shares Bought by New York State Common Retirement Fund - MarketBeat
Labcorp Holdings Inc. $LH Shares Acquired by Raleigh Capital Management Inc. - MarketBeat
S P Trends: Can Labcorp Holdings Inc disrupt its industry2025 Bull vs Bear & High Accuracy Investment Signals - baoquankhu1.vn
Labcorp Holdings Inc. $LH Shares Purchased by Independent Advisor Alliance - MarketBeat
Aug Spikes: Does Labcorp Holdings Inc have pricing powerQuarterly Trade Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
A Look At Labcorp Holdings (LH) Valuation After Receivables Facility Extension And Added Accordion Feature - Sahm
Labcorp Holdings Inc. $LH Shares Bought by Thrivent Financial for Lutherans - MarketBeat
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Labcorp Extends Receivables Facility, Enhances Liquidity Flexibility - The Globe and Mail
Bank of New York Mellon Corp Sells 23,382 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. $LH Stake Reduced by Cambiar Investors LLC - MarketBeat
What Makes Labcorp (LH) a New Buy Stock - sharewise.com
Labcorp Holdings Inc. $LH Shares Sold by Cooke & Bieler LP - MarketBeat
Sector Gamma AS Acquires 6,486 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Strs Ohio Reduces Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (NYSE:LH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Labcorp (NYSE:LH) Upgraded to Buy at Wall Street Zen - MarketBeat
Expanded MRD Test Suite and Dividend Hike Might Change The Case For Investing In Labcorp (LH) - simplywall.st
QRG Capital Management Inc. Has $878,000 Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
The Price Is Right For Labcorp Holdings Inc. (NYSE:LH) - 富途资讯
Labcorp Holdings Inc. $LH Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Navera Investment Management Ltd. Sells 11,643 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Community Health Completes Asset Sale to LabCorp - MSN
Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72 - simplywall.st
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance
Campbell & CO Investment Adviser LLC Invests $1.97 Million in Labcorp Holdings Inc. $LH - MarketBeat
Ideas Watch: Can Labcorp Holdings Inc disrupt its industryPrice Action & Daily Growth Stock Tips - baoquankhu1.vn
Labcorp to Settle Patient Privacy Dispute Over Online Trackers - Bloomberg Law News
Manning & Napier Advisors LLC Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp’s quarterly earnings preview: What you need to know - MSN
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? - Yahoo Finance
Labcorp Holdings Board Declares Quarterly Cash Dividend - The Globe and Mail
Labcorp Schedules Q4 2025 Earnings Release and Call - TipRanks
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - Finviz
Labcorp Holdings Inc to Announce Q4 2025 Financial Results - TradingView — Track All Markets
A Look At Labcorp (LH) Valuation After Expanding Its MRD Cancer Testing Portfolio - Sahm
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):